Neuroscience
From today's Guardian:
Major drug trial highlights a new approach in stroke prevention
The success of Pradaxa in a 44-country trial indicates a possible end to the use of the rat poison warfarin as a primary treatment to prevent stroke
Press Association
guardian.co.uk
Sunday 30 August 2009 23.27 BST
Read the full article
Boehringer Ingelheim's (BI) corporate website information about their clinical trial programmes: click here
- Alzheimer Disease: Targacept's Failed Tc-1734 Phase 2b Trial
From a Targacept press release:Targacept Phase 2b Clinical Trial in Alzheimer’s Disease Does Not Show Superiority of TC-1734 Over Donepezil July 14, 2014 "Winston-Salem, NC – Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company...
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Traumatic Brain Injury: Progesterone Clinical Trial
From The Guardian: Sex hormone progesterone may save lives after brain injury A major clinical trial will test whether the female sex hormone can minimise damage and improve recovery after brain injury Ian Sample, San Diego guardian.co.uk Friday 19 February...
- Stroke And Tissue Plasminogen Activator (tpa) Treatment
From The Globe and Mail: Stroke drug grossly underused, experts say The Globe and Mail 07 February 2005 [snip] TPA remains the sole drug approved for strokes. Yet only about 3 per cent of victims get it. Usually that's because they don't...
- Outcome Of Fda Meeting About Exanta
The Associated Press reported this evening about today's FDA meeting (see yesterday's post: Forthcoming Meeting...): FDA Panel Urges More Studies of Stroke Med By THE ASSOCIATED PRESS (copyright) Filed at 8:51 p.m. ET WILMINGTON, Del....
Neuroscience
Clinical Trials: Pradaxa (dabigatran etexilate) and Stroke Prevention
From today's Guardian:
Major drug trial highlights a new approach in stroke prevention
The success of Pradaxa in a 44-country trial indicates a possible end to the use of the rat poison warfarin as a primary treatment to prevent stroke
Press Association
guardian.co.uk
Sunday 30 August 2009 23.27 BST
Read the full article
Boehringer Ingelheim's (BI) corporate website information about their clinical trial programmes: click here
- Alzheimer Disease: Targacept's Failed Tc-1734 Phase 2b Trial
From a Targacept press release:Targacept Phase 2b Clinical Trial in Alzheimer’s Disease Does Not Show Superiority of TC-1734 Over Donepezil July 14, 2014 "Winston-Salem, NC – Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company...
- Alzheimer's Disease: Negative Bapineuzumab Findings In Phase Iii Trial
Critical reading for those interested in Alzheimer's clinical trials: first results from the BAP Phase III program. The link includes additional links to a New York Times article and a company press release. From FierceBiotech: UPDATED: Pfizer, J&J...
- Traumatic Brain Injury: Progesterone Clinical Trial
From The Guardian: Sex hormone progesterone may save lives after brain injury A major clinical trial will test whether the female sex hormone can minimise damage and improve recovery after brain injury Ian Sample, San Diego guardian.co.uk Friday 19 February...
- Stroke And Tissue Plasminogen Activator (tpa) Treatment
From The Globe and Mail: Stroke drug grossly underused, experts say The Globe and Mail 07 February 2005 [snip] TPA remains the sole drug approved for strokes. Yet only about 3 per cent of victims get it. Usually that's because they don't...
- Outcome Of Fda Meeting About Exanta
The Associated Press reported this evening about today's FDA meeting (see yesterday's post: Forthcoming Meeting...): FDA Panel Urges More Studies of Stroke Med By THE ASSOCIATED PRESS (copyright) Filed at 8:51 p.m. ET WILMINGTON, Del....